Therapeutic effects of histone deacetylase inhibitors on kidney disease

Area of Science:

• Nephrology
• Molecular Biology
• Pharmacology

Background:

• Histone deacetylases (HDACs) play a significant role in the development and progression of diverse renal diseases.
• HDAC inhibition is emerging as a potential therapeutic strategy for preventing kidney diseases.

Purpose of the Study:

• To review the roles of HDAC inhibitors in experimental kidney disease models.
• To elucidate the mechanisms underlying the therapeutic effects of HDAC inhibitors in renal pathologies.
• To guide the development of more effective and safer isoform-selective HDAC inhibitors.

Main Methods:

• Comprehensive literature review of studies investigating HDAC inhibitors in experimental renal disease models.
• Analysis of pathways targeted by HDAC inhibitors, including TGF-β and NF-κB signaling.
• Examination of effects on apoptosis and angiogenesis in the context of kidney disease.

Main Results:

• HDAC inhibitors demonstrate protective effects in various kidney diseases.
• Therapeutic mechanisms include suppression of pro-inflammatory and pro-fibrotic signaling pathways.
• HDAC inhibitors modulate apoptosis and angiogenesis, contributing to renoprotection.

Conclusions:

• HDAC inhibitors offer a promising therapeutic avenue for managing a spectrum of kidney diseases.
• Understanding HDAC inhibitor mechanisms is vital for optimizing their clinical application.
• Further development of isoform-selective HDAC inhibitors is warranted to improve patient outcomes in renal diseases.